Encouraging Study Results for an Inactivated SARS-CoV-2 Vaccine
Link: Rapid Development of An Inactivated Vaccine for SARS-CoV-2
Researchers in the above study developed a pilot-scale production of a purified inactivated SARS-CoV-2 vaccine. Administration of the vaccine induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates.
The antibodies produced in the animals neutralized 10 different SARS-CoV-2 strains. Immunization with two different doses provided partial or complete protection (in macaques). Systematic evaluation of the vaccine that it’s safe in macaques.
Early data to be sure, but encouraging.
